KEAP1 and lung cancer: Additionally, inhibition of the PI3K/AKT pathway markedly reduces endogenous NRF2 protein and enzymes in KEAP1-mutant lung cancer cells and KEAP1-deficient mouse embryonic fibroblasts (MEFs) [40].